MillionMilesAway
Well-Known Member
Looking awkward for Oxford vaccine. US yet to give it the green light to restart trials and without trials how do we determine how significant the risk of adverse reactions are? Unfortunately we do not even know if the illnesses which the triallists had were vaccine related but it seems to have spooked the US regulators.
Looks like there have been a couple of cases of spinal cord inflammation which would limit mobility.
There shouldn't really be an announcement of what caused them until the trial runs its course or is shut down - the people running it know what they're looking at. Bit odd for US regulators to be iffy over this while UK regulators are happy to continue - I agree that that does look strange.